GlassScriptPhysician profile
Michael A Leong
NPI 1114031259
$4,395.87
in general payments reported to CMS, 2019-2025
13 companies · $1,256 in 2025
The $1,256 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $204 · 2021: $146 · 2022: $662 · 2023: $325 · 2024: $866 · 2025: $1,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,342 · Entertainment: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,341.53 |
| Entertainment | $104.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $886.85 | 2022-2025 | Infuse, Biotrue One Day, Miebo |
| Johnson & Johnson Vision Care, INC. | $757.40 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $750.68 | 2019-2021 | |
| Amgen INC. | $343.61 | 2024-2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $298.45 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $294.50 | 2022-2025 | Rocklatan, Simbrinza, Rhopressa |
| Sight Sciences, INC. | $232.08 | 2024-2025 | Tearcare System, Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $218.43 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $184.72 | 2025 | |
| Coopervision INC. | $163.19 | 2020-2025 | Misight Contact Lens |
| Abbvie INC. | $123.60 | 2022 | |
| Optos, INC. | $104.35 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $38.01 | 2021-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Leong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.